Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cutting edge: Requirement for growth hormone-releasing hormone in the development of experimental autoimmune encephalomyelitis.

Journal of immunology (Baltimore, Md. : 1950) - 15 Sept 2003

Ikushima Hideto, Kanaoka Masaharu, Kojima Shinichi

Abstract excerpt

Growth hormone (GH)-releasing hormone (GHRH) is a neuropeptide that stimulates secretion of GH from the pituitary gland. Although GHRH and its receptor (GHRHR) are expressed in leukocytes, physiological function of GHRH in the immune system remains unclear. To study the influence of GHRH in autoi...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Encephalomyelitis, Autoimmune, Experimental
Share to Glycoproteins
Share to Growth Hormone-Releasing Hormone

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunodominant Epitopes

Share to Mice, Mutant Strains

Share to Myelin-Oligodendrocyte Glycoprotein

Share to Receptors, Neuropeptide

Share to Receptors, Pituitary Hormone-Regulating Hormone

Source

Identifiers

PMID: 12960295
DOI: 10.4049/jimmunol.171.6.2769

Genes

GHRH
MOG
GHRHR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12960295-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cutting edge: Requirement for growth hormone-releasing hormone in the development of experimental autoimmune encephalomyelitis.PMID 12960295Read ↗

Beta Adrenergic Signaling as a Therapeutic Target for AutoimmunitySemantic proximity Read ↗

Stress, the immune system and vulnerability to degenerative disorders of the central nervous system in transgenic mice expressing glucocorticoid receptor antisense RNA.Semantic proximity Read ↗

Histamine H₂ receptor signaling × environment interactions determine susceptibility to experimental allergic encephalomyelitis.Semantic proximity Read ↗

Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cellsSemantic proximity Read ↗

Stress, glucocorticoids and the susceptibility to develop autoimmune disorders of the central nervous system.Semantic proximity Read ↗

IL-7Rα confers susceptibility to experimental autoimmune encephalomyelitis.Semantic proximity Read ↗

Histamine H(3) receptor integrates peripheral inflammatory signals in the neurogenic control of immune responses and autoimmune disease susceptibility.Semantic proximity Read ↗

Requirement for leptin in the induction and progression of autoimmune encephalomyelitis.Semantic proximity Read ↗

H(1)R expression by CD11B(+) cells is not required for susceptibility to experimental allergic encephalomyelitis.Semantic proximity Read ↗

Beta-adrenoceptor blockade ameliorates the clinical course of experimental allergic encephalomyelitis and diminishes its aggravation in adrenalectomized rats.Semantic proximity Read ↗

Myelin/oligodendrocyte glycoprotein-deficient (MOG-deficient) mice reveal lack of immune tolerance to MOG in wild-type mice.Semantic proximity Read ↗

Behavioural phenotyping of male growth hormone-releasing hormone (GHRH) knockout mice.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.